NUVL
NUVL
NASDAQ · Biotechnology

Nuvalent Inc-A

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$123.96
+0.02 (+0.02%)
As of Oct 24, 1:19 AM ET ·
Analyst Consensus
Hold
23
Analysts
High
Coverage
Buy 8 35%
Hold 15 65%
Sell 0 0%
Price Target
Analyst Price Target -73.2% upside
Low Target $20.12
Average Target $33.28
High Target $44.46
Current Price $123.96
Current
$123.96
Target
$33.28
$20.12 $33.28 avg $44.46
Scenario Analysis
Bear Case
$20.12
-83.8%
Low target
Base Case
$33.28
-73.2%
Avg target
Bull Case
$44.46
+-64.1%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$123.99
0.0% from high
52-Week Low
$87.30
+42.0% from low
50-Day SMA
$103.19
+20.1% vs SMA
200-Day SMA
$97.75
+26.8% vs SMA
RSI (14)
63.7
Neutral
Target vs 52W High
$33.28
-73.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%